100 related articles for article (PubMed ID: 30101)
21. Effects of naloxone on schizophrenia: reduction in hallucinations in a subpopulation of subjects.
Watson SJ; Berger PA; Akil H; Mills MJ; Barchas JD
Science; 1978 Jul; 201(4350):73-6. PubMed ID: 351804
[TBL] [Abstract][Full Text] [Related]
22. Effect of naloxone on acute stroke.
Czlonkowska A; Cyrta B
Pharmacopsychiatry; 1988 Mar; 21(2):98-100. PubMed ID: 3293092
[TBL] [Abstract][Full Text] [Related]
23. Time course of antipsychotic effects of neuroleptic drugs.
Keck PE; Cohen BM; Baldessarini RJ; McElroy SL
Am J Psychiatry; 1989 Oct; 146(10):1289-92. PubMed ID: 2571305
[TBL] [Abstract][Full Text] [Related]
24. Naloxone-induced reduction of schizophrenic symptoms.
Jørgensen HA; Cappelen C
Acta Psychiatr Scand; 1982 May; 65(5):370-4. PubMed ID: 6126068
[TBL] [Abstract][Full Text] [Related]
25. Short-term naloxone administration in schizophrenic and manic patients. A World Health Organization Collaborative Study.
Pickar D; Vartanian F; Bunney WE; Maier HP; Gastpar MT; Prakash R; Sethi BB; Lideman R; Belyaev BS; Tsutsulkovskaja MV; Jungkunz G; Nedopil N; Verhoeven W; van Praag H
Arch Gen Psychiatry; 1982 Mar; 39(3):313-9. PubMed ID: 6121545
[TBL] [Abstract][Full Text] [Related]
26. Lack of effect on naloxone on schizophrenic symptoms.
Janowsky DS; Segal DS; Bloom F; Abrams A; Guillemin R
Am J Psychiatry; 1977 Aug; 134(8):926-7. PubMed ID: 879360
[No Abstract] [Full Text] [Related]
27. Lack of effect of naloxone and schizophrenic auditory hallucinations.
Freeman CP; Fairburn CG
Psychol Med; 1981 May; 11(2):405-7. PubMed ID: 7022531
[No Abstract] [Full Text] [Related]
28. beta-Endorphin and naloxone in psychiatric patients: clinical and biological effects.
Lehmann H; Nair NP; Kline NS
Am J Psychiatry; 1979 Jun; 136(6):762-6. PubMed ID: 220889
[TBL] [Abstract][Full Text] [Related]
29. Use of naloxone in schizophrenic psychoses and manic syndromes.
Verhoeven WM; van Praag HM; de Jong JT
Neuropsychobiology; 1981; 7(3):159-68. PubMed ID: 7231653
[TBL] [Abstract][Full Text] [Related]
30. Naloxone reverses ethanol-induced depression of hypercapnic drive.
Michiels TM; Light RW; Mahutte CK
Am Rev Respir Dis; 1983 Nov; 128(5):823-6. PubMed ID: 6357014
[TBL] [Abstract][Full Text] [Related]
31. Repeated naloxone administration in schizophrenia.
Verhoeven WM; van Praag HM; van Ree JM
Psychiatry Res; 1984 Aug; 12(4):297-312. PubMed ID: 6594713
[TBL] [Abstract][Full Text] [Related]
32. Therapeutical significance of clopimozide in the treatment of chronic psychotic patients.
De Cuyper HJ; Van Praag HM; Mulder WR
Acta Psychiatr Scand; 1979 May; 59(5):561-74. PubMed ID: 37697
[TBL] [Abstract][Full Text] [Related]
33. Naloxone-induced reversal of schizophrenic hallucinations.
Gunne LM; Lindström L; Terenius L
J Neural Transm; 1977; 40(1):13-9. PubMed ID: 319204
[TBL] [Abstract][Full Text] [Related]
34. Naloxone in chronic schizophrenia.
Volavka J; Mallya A; Baig S; Perez-Cruet J
Science; 1977 Jun; 196(4295):1227-8. PubMed ID: 860138
[TBL] [Abstract][Full Text] [Related]
35. Naloxone in schizophrenia.
Skrabanek P
Lancet; 1982 Dec; 2(8310):1270. PubMed ID: 6128561
[No Abstract] [Full Text] [Related]
36. Action of naloxone and naltrexone in different types of psychoses.
Volavka J
Mod Probl Pharmacopsychiatry; 1981; 17():202-12. PubMed ID: 6276726
[No Abstract] [Full Text] [Related]
37. Research in endorphins and schizophrenia.
Davis GC; Buchsbaum MS; Bunney WE
Schizophr Bull; 1979; 5(2):244-50. PubMed ID: 37596
[TBL] [Abstract][Full Text] [Related]
38. Repeated naloxone administration in schizophrenia: a phase II World Health Organization Study.
Pickar D; Bunney WE; Douillet P; Sethi BB; Sharma M; Vartanian ME; Lideman RP; Naber D; Leibl K; Yamashita I
Biol Psychiatry; 1989 Feb; 25(4):440-8. PubMed ID: 2539206
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid [Met5]enkephalin level in schizophrenics during treatment with naloxone.
Lo CW; Wen HL; Ho WK
Eur J Pharmacol; 1983 Aug; 92(1-2):77-81. PubMed ID: 6138259
[TBL] [Abstract][Full Text] [Related]
40. Naloxone, a specific opioid antagonist, reverses chronic idiopathic constipation.
Kreek MJ; Schaefer RA; Hahn EF; Fishman J
Lancet; 1983 Feb; 1(8319):261-2. PubMed ID: 6130292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
